EU Pharma Strategy Will Remove Barriers And Bolster Competition
Proposals Promise ‘Targeted Policies’ To Boost Generics And Biosimilars
The European Commission’s newly-published Pharmaceutical Strategy features a range of proposals related to generics and biosimilars, including “targeted policies” to improve competition, remove barriers and increase uptake.
